Alisa Opar

439 total citations
43 papers, 355 citations indexed

About

Alisa Opar is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Surgery. According to data from OpenAlex, Alisa Opar has authored 43 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 7 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Alisa Opar's work include Pharmaceutical studies and practices (4 papers), Health and Medical Research Impacts (3 papers) and Computational Drug Discovery Methods (3 papers). Alisa Opar is often cited by papers focused on Pharmaceutical studies and practices (4 papers), Health and Medical Research Impacts (3 papers) and Computational Drug Discovery Methods (3 papers). Alisa Opar collaborates with scholars based in Bangladesh and United States. Alisa Opar's co-authors include Alexander van Geen, Ashraf Ali Seddique, Joseph H. Graziano, Kazi Matin Ahmed and Alex Pfaff and has published in prestigious journals such as Nature Medicine, Nature Reviews Drug Discovery and Health & Place.

In The Last Decade

Alisa Opar

41 papers receiving 332 citations

Peers

Alisa Opar
Michelle Thunders New Zealand
Troy Seidle United States
Ying Xie China
Robbert Zusterzeel United States
Edward D. Bashaw United States
Patricia Guzmán Mexico
Xiguang Liu China
Karen Chiu United States
Mario Bermúdez de León Mexico
Jianliang Xu China
Michelle Thunders New Zealand
Alisa Opar
Citations per year, relative to Alisa Opar Alisa Opar (= 1×) peers Michelle Thunders

Countries citing papers authored by Alisa Opar

Since Specialization
Citations

This map shows the geographic impact of Alisa Opar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alisa Opar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alisa Opar more than expected).

Fields of papers citing papers by Alisa Opar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alisa Opar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alisa Opar. The network helps show where Alisa Opar may publish in the future.

Co-authorship network of co-authors of Alisa Opar

This figure shows the co-authorship network connecting the top 25 collaborators of Alisa Opar. A scholar is included among the top collaborators of Alisa Opar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alisa Opar. Alisa Opar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Opar, Alisa. (2019). CRISPR-edited babies arrived, and regulators are still racing to catch up. Nature Medicine. 25(11). 1634–1636. 4 indexed citations
2.
Opar, Alisa. (2012). Overactive bladder, under scrutiny, gets a new treatment. Nature Medicine. 18(8). 1159–1159. 3 indexed citations
3.
Opar, Alisa. (2012). Exon-skipping drug pulls ahead in muscular dystrophy field. Nature Medicine. 18(9). 1314–1314. 5 indexed citations
4.
Opar, Alisa. (2011). 'Pharmers' hope for first plant drug harvest. Nature Reviews Drug Discovery. 10(2). 81–82. 12 indexed citations
5.
Opar, Alisa. (2011). Excitement mounts for first disease-modifying cystic fibrosis drugs. Nature Reviews Drug Discovery. 10(7). 479–480. 4 indexed citations
6.
Opar, Alisa. (2011). Quarter-century quest for malaria vaccine shows signs of success. Nature Reviews Drug Discovery. 10(12). 887–888. 4 indexed citations
7.
Opar, Alisa. (2011). Mysteries about drug metabolism in the obese weigh on doctors. Nature Medicine. 17(10). 1158–1158.
8.
Opar, Alisa. (2010). Excitement grows for potential revolution in hepatitis C virus treatment. Nature Reviews Drug Discovery. 9(7). 501–503. 18 indexed citations
9.
Opar, Alisa. (2010). Lind guidelines offer a checklist for research priorities. Nature Medicine. 16(6). 620–620. 1 indexed citations
10.
Opar, Alisa. (2009). A close look at acid reflux drugs points to possible risks. Nature Medicine. 15(7). 710–710. 2 indexed citations
11.
Opar, Alisa. (2008). ASCO presentations highlight value of cancer biomarkers. Nature Reviews Drug Discovery. 7(7). 547–548. 1 indexed citations
12.
Opar, Alisa. (2008). Amidst challenges, UK research hub moves closer to relocation. Nature Medicine. 14(1). 4–4. 1 indexed citations
13.
Opar, Alisa. (2008). Another blow for inhaled protein therapeutics. Nature Reviews Drug Discovery. 7(3). 189–190. 4 indexed citations
14.
Opar, Alisa. (2008). Common reproductive disorders may have immunological basis. Nature Medicine. 14(11). 1172–1172. 1 indexed citations
15.
Opar, Alisa. (2007). US tosses out patents on three Wisconsin stem cell lines. Nature Medicine. 13(5). 519–519. 1 indexed citations
16.
Opar, Alisa. (2007). Where now for new drugs for atherosclerosis?. Nature Reviews Drug Discovery. 6(5). 334–335. 12 indexed citations
17.
Opar, Alisa. (2007). DDT's ability to repel mosquitoes trumps resistance, scientists say. Nature Medicine. 13(9). 1002–1003. 2 indexed citations
18.
Opar, Alisa. (2007). New schemes aim to boost minority participation in research. Nature Medicine. 13(7). 764–765. 3 indexed citations
19.
Opar, Alisa, Alex Pfaff, Ashraf Ali Seddique, et al.. (2006). Responses of 6500 households to arsenic mitigation in Araihazar, Bangladesh. Health & Place. 13(1). 164–172. 78 indexed citations
20.
Opar, Alisa. (2006). German foundation helps women juggle science and family. Nature Medicine. 12(7). 720–720. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelle Thunders Breakdown of academic impact, for papers by Troy Seidle Breakdown of academic impact, for papers by Ying Xie Breakdown of academic impact, for papers by Robbert Zusterzeel Breakdown of academic impact, for papers by Edward D. Bashaw Breakdown of academic impact, for papers by Patricia Guzmán Breakdown of academic impact, for papers by Xiguang Liu Breakdown of academic impact, for papers by Karen Chiu Breakdown of academic impact, for papers by Mario Bermúdez de León Breakdown of academic impact, for papers by Jianliang Xu
Rankless by CCL
2026